Insulin Pathway
Insulin Receptor: Core Identity
Belongs to the family of receptor tyrosine kinases (RTKs).
Functions as both receptor and enzyme: the cytoplasmic domain possesses intrinsic kinase activity.
Canonical activation sequence:
Insulin (ligand) binds the extracellular α‐subunits.
Receptor dimers cluster (dimerize/oligomerize).
Autophosphorylation occurs on multiple tyrosine residues of the intracellular β‐subunits.
Creates high-affinity docking sites bearing phosphorylated tyrosines that are recognized by proteins with SH2 (Src-homology-2) domains.
Docking Protein: IRS-1
Insulin Receptor Substrate-1 is the primary adaptor.
Contains multiple Tyr motifs; each can be further phosphorylated to serve as platforms for distinct downstream enzymes.
IRS-1 integrates and bifurcates the signal into at least two well-studied cascades:
The RAS–MAPK (mitogenic) pathway (discussed in previous lecture).
The PI3K–Akt (metabolic) pathway (focus of current discussion).
Branch Choice: Focusing on the PI3K–Akt Arm
Once bound to phosphorylated IRS-1, phosphatidylinositol 3-kinase (PI3K) is itself phosphorylated and activated.
PI3K Catalytic Action
Substrate: membrane phospholipid PIP₂ (phosphatidylinositol 4,5-bisphosphate).
Reaction (simplified):
Product: PIP₃ (phosphatidylinositol 3,4,5-trisphosphate).
Distinct from IP₃/DAG generation by phospholipase C (mentioned to prevent confusion with the IP₃ pathway).
Acts as a lipid second messenger, remaining within the inner leaflet of the plasma membrane.
Recruitment & Activation of Akt (Protein Kinase B)
PIP₃ forms docking sites for proteins with pleckstrin homology (PH) domains; chief among them is Akt.
Akt is phosphorylated at key residues (Thr308, Ser473 in mammals) → conformationally active.
Once active, Akt mediates two central metabolic effects of insulin:
1. GLUT4 Vesicle Translocation
Cytosolic vesicles containing the GLUT4 glucose transporter are constitutively present but sequestered.
Akt triggers rapid exocytosis/fusion of these vesicles with the plasma membrane.
Result: sharp increase in membrane GLUT4 density → accelerated facilitated diffusion of extracellular glucose into the cell (especially in adipose tissue and skeletal muscle).
2. Promotion of Glycogen Synthesis
Via an indirect cascade (details not required for the exam):
Akt inhibits GSK-3 (glycogen synthase kinase-3).
Inhibition of GSK-3 relieves its inhibitory phosphorylation on glycogen synthase.
Net outcome: active glycogen synthase catalyzes polymerization of incoming glucose units into glycogen:
Integrated Physiological Outcome
Insulin, through PI3K–Akt:
Drives glucose uptake (GLUT4 insertion).
Drives glucose storage (glycogen synthesis).
Complements the RAS–MAPK route, which is more concerned with growth, differentiation, and gene expression.
Connections & Context
Distinction from IP₃/DAG signaling: although PIP₂ is a common precursor, PI3K phosphorylates it (adds a phosphate) rather than cleaving it (as PLC does).
Disorders:
Impaired PI3K/Akt signaling → insulin resistance, hallmark of type 2 diabetes.
Over-activation in oncogenic settings yields enhanced growth and survival signals (Akt is frequently hyper-active in cancers).
Therapeutic angles:
Drugs enhancing GLUT4 translocation mimic or augment the Akt effect.
PI3K or Akt inhibitors are explored in oncology.
Key Terms Recap (Flash-Style)
RTK – receptor tyrosine kinase.
IRS-1 – adaptor with SH2 docking motifs.
PI3K – lipid kinase turning PIP₂ → PIP₃.
PIP₃ – membrane lipid second messenger.
Akt/PKB – serine/threonine kinase, central metabolic switch.
GLUT4 – insulin-responsive glucose transporter.
Glycogen Synthase – enzyme linking glucose → glycogen.
Numerical / Molecular Data
Phosphorylation states: has 2 phosphate groups; has 3.
ATP consumption: 1 ATP per PIP₂ phosphorylated by PI3K.
Akt key residues: .
Overall glucose polymerization stoichiometry summarized above.
Ethical & Practical Implications
Understanding this pathway informs treatment strategies for metabolic diseases and cancer.
Illustrates how a single hormone can orchestrate broad cellular changes via branching signaling networks.